Literature DB >> 2445438

Retrograde transneuronal transfer of herpes simplex virus type 1 (HSV 1) from motoneurones.

G Ugolini1, H G Kuypers, A Simmons.   

Abstract

The use of Herpes simplex virus (HSV) as a retrograde transneuronal tracer would have the unique advantage that the virus would be replicated in the second order neurones, resulting in strong labelling. HSV was injected in the XII nerve (mice). The virus was detected immunohistochemically. Four stages in the brainstem distribution of HSV-positive neurones were distinguished. These stages were correlated with injected amounts/survival time. In stage 1, positive neurones were restricted to the XII nucleus; glial cells were present around the intramedullary XII rootlets. In stages 2-4, positive neurones and glial cells were also present outside the XII nucleus: (a) in the lateral reticular formation, Kölliker-Fuse nucleus, raphe and nucleus coeruleus; and (b) in the area around the XII rootlets, including parts of the inferior olive. In view of their distribution, many of the neurones in (a) must have received the virus by retrograde transneuronal transfer from XII motoneurones. The neurones in (b) were probably infected through a different route, i.e. local transfer of virus from XII axons via glial cells. This local transfer does not lead to extensive spread of the infection, yet, when using HSV for retrograde transneuronal tracing it may represent a source of error.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2445438     DOI: 10.1016/0006-8993(87)90931-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  34 in total

1.  Divergent molecular pathways of productive and latent infection with a virulent strain of herpes simplex virus type 1.

Authors:  P G Speck; A Simmons
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons.

Authors:  Ian R Wickersham; David C Lyon; Richard J O Barnard; Takuma Mori; Stefan Finke; Karl-Klaus Conzelmann; John A T Young; Edward M Callaway
Journal:  Neuron       Date:  2007-03-01       Impact factor: 17.173

3.  5-HT1B autoreceptors differentially modulate the expression of conditioned fear in a circuit-specific manner.

Authors:  Y Liu; M A Kelly; T J Sexton; J F Neumaier
Journal:  Neuroscience       Date:  2015-04-20       Impact factor: 3.590

4.  The transneuronal spread phenotype of herpes simplex virus type 1 infection of the mouse hind footpad.

Authors:  J P Engel; T C Madigan; G M Peterson
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

5.  Production of glycoprotein-deleted rabies viruses for monosynaptic tracing and high-level gene expression in neurons.

Authors:  Ian R Wickersham; Heather A Sullivan; H Sebastian Seung
Journal:  Nat Protoc       Date:  2010-03-04       Impact factor: 13.491

6.  Selective spread of herpes simplex virus in the central nervous system after ocular inoculation.

Authors:  T P Margolis; J H LaVail; P Y Setzer; C R Dawson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

7.  Stage-dependent remodeling of projections to motor cortex in ALS mouse model revealed by a new variant retrograde-AAV9.

Authors:  Barbara Commisso; Lingjun Ding; Karl Varadi; Martin Gorges; David Bayer; Tobias M Boeckers; Albert C Ludolph; Jan Kassubek; Oliver J Müller; Francesco Roselli
Journal:  Elife       Date:  2018-08-23       Impact factor: 8.140

8.  Monosynaptic inputs to ErbB4-expressing inhibitory neurons in mouse primary somatosensory cortex.

Authors:  Jiwon Choi; Edward M Callaway
Journal:  J Comp Neurol       Date:  2011-12-01       Impact factor: 3.215

Review 9.  Gene transfer in the nervous system and implications for transsynaptic neuronal tracing.

Authors:  Youngbuhm Huh; Myung S Oh; Pierre Leblanc; Kwang-Soo Kim
Journal:  Expert Opin Biol Ther       Date:  2010-05       Impact factor: 4.388

10.  Penetration of the nervous systems of suckling mice by mammalian reoviruses.

Authors:  A Flamand; J P Gagner; L A Morrison; B N Fields
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.